In T cells, both SAM and MTA levels impact methylation status, with elevated concentrations of either leading to T cell deficiency, and restricting MAT2A in T cells can enhance their activity within the hepatocellular carcinoma microenvironment, thereby inhibiting tumor growth.34 This evidence concerns the gene MAT2A and congenital T-cell immunodeficiency.